Company
Optigenex, Inc.
Headquarters: Melissa, TX, United States
CEO: Mr. Daniel Zwiren
Optigenex, Inc. Categories
United States Healthcare Diagnostics & ResearchUnited States Healthcare United States Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $162.07 B |
| Danaher | $144.92 B |
| Siemens Healthineers AG | $64.17 B |
| Lonza Group Ltd | $49.67 B |
| IDEXX Laboratories, Inc. | $43.99 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
Optigenex Inc. engages in the manufacture and sale of healthy age management and beauty care products. The company offers AC-11, a powdered and bioactive rainforest plant extract that helps the body to repair sun and environmental stress-related damage to DNA, and slow down the process of skin aging. It serves manufacturers, distributors, and retailers worldwide in the dietary supplement, as well as anti-aging topical skin care, cosmetic, and cosmeceutical market categories. The company is based in Melissa, Texas.
Stocks & Indices
Optigenex, Inc. has the following listings and related stock indices.
Stock: OTC: OPGX wb_incandescent